Foresite Capital Management V as of Sept. 30, 2022
Portfolio Holdings for Foresite Capital Management V
Foresite Capital Management V holds 14 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aclaris Therapeutics (ACRS) | 15.2 | $20M | 1.3M | 15.74 | |
| Theseus Pharmaceuticals | 14.9 | $19M | 3.3M | 5.80 | |
| Hims & Hers Health Com Cl A (HIMS) | 14.2 | $19M | 3.3M | 5.58 | |
| Pardes Biosciences | 13.4 | $17M | 9.4M | 1.85 | |
| Kinnate Biopharma (KNTE) | 8.0 | $11M | 875k | 11.95 | |
| Somalogic Com Cl A | 7.8 | $10M | 3.5M | 2.90 | |
| Compass Therapeutics (CMPX) | 7.7 | $10M | 4.4M | 2.28 | |
| Adicet Bio (ACET) | 7.4 | $9.7M | 680k | 14.22 | |
| Adagio Therapeutics (IVVD) | 3.4 | $4.5M | 1.4M | 3.13 | |
| Gemini Therapeutics | 3.1 | $4.0M | 2.4M | 1.64 | |
| Quantum-Si Incorporated Com Cl A (QSI) | 2.0 | $2.5M | 924k | 2.75 | |
| Enanta Pharmaceuticals (ENTA) | 1.7 | $2.2M | 42k | 51.88 | |
| 23andMe Holding Com Cl A (ME) | 0.9 | $1.2M | 407k | 2.86 | |
| Pharvaris N V (PHVS) | 0.2 | $262k | 34k | 7.67 |
